Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Clinical trial NCT00431795 · TERMINATED
Trial details
- NCT number
- NCT00431795
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2012-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.